Insider trades
Martha Morrell, Chief Officer of NeuroPace NPCE, has filed 0 purchases and 16 sales on the open market. Over the past 12 months that comes to a net sale of $399.2K. The latest trade was on 09/24.
Martha Morrell
Chief Medical Officer
- Company
- NeuroPace NPCE
- First filing
- 23/02/22
- Trades
- 79 trades
- Buys / sales
- 0 / 16
- 12-month net buying
- −$399.3K
- Last trade
- 09/24
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
NeuroPaceNPCE | Open-market sale | 25/12/15 | 03/04 | 25,000 sh | $15.97 | $399,250 | −33.3% |
NeuroPaceNPCE | Open-market sale | 25/02/21 | 25/02/25 | 78,334 sh | $13.72 | $1,074,742.48 | −48.9% |
NPCE | Open-market sale10b5-1 plan | 25/01/29–25/01/30 | 25/01/31 | 300 sh2 trades | $15.00avg. | $4,500 | −0.3% |
NeuroPaceNPCE | Open-market sale10b5-1 plan | 25/01/24 | 25/01/28 | 3,200 sh | $15.01 | $48,032 | −3.5% |
NPCE | Open-market sale | 24/02/02–24/02/05 | 24/02/06 | 17,589 sh2 trades | $15.09avg. | $265,410.83 | −18.4% |
NPCE | Open-market sale | 24/01/30–24/02/01 | 24/02/01 | 13,848 sh3 trades | $15.09avg. | $209,026.56 | −12.7% |
NPCE | Open-market sale | 24/01/24–24/01/25 | 24/01/26 | 828 sh2 trades | $15.03avg. | $12,444.81 | −0.8% |
NPCE | Open-market sale | 23/12/26–23/12/27 | 23/12/28 | 13,402 sh2 trades | $10.12avg. | $135,616 | −10.9% |
NeuroPaceNPCE | Open-market sale | 23/12/20 | 23/12/22 | 2,730 sh | $10.14 | $27,682.2 | −2.2% |
NeuroPaceNPCE | Open-market sale | 23/12/06 | 23/12/07 | 11,005 sh | $8.16 | $89,800.8 | −8.0% |